Timolol/Latanoprost (Novaliq)

噻吗洛尔/拉坦前列素 (Novaliq)

Report date: 2025/10/27 17:55:55

Base Information

Drug NameTimolol/Latanoprost (Novaliq)
Drug Alias NameBTQ-2302
ClassificationSmall molecules
Mechanisms of ActionProstanoid FP receptor agonistsBeta adrenergic receptors antagonists
TargetsProstanoid FP receptorBeta adrenergic receptors
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovaliq Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesNovaliq Gmbh
Inactive CompaniesN/A
Active IndicationsXerophthalmia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A